-
1
-
-
84876111160
-
-
ASCO guidelines (http://www.asco.org/guidelines/larynx)
-
ASCO Guidelines
-
-
-
2
-
-
77951802564
-
-
NCI guideline (http://www.cancer.gov/cancertopics/pdq/treatment/ laryngeal/HealthProfessional/)
-
NCI Guideline
-
-
-
3
-
-
77951875634
-
-
Japanese source
-
-
-
-
4
-
-
33747032033
-
American society of clinical oncology clinical practice guideline for the use of larynx-preservation strategies in the treatment of laryngeal cancer
-
David G et al : American society of clinical oncology clinical practice guideline for the use of larynx-preservation strategies in the treatment of laryngeal cancer. J Clin Oncol 24: 3693-3704, 2006
-
(2006)
J Clin Oncol
, vol.24
, pp. 3693-3704
-
-
David, G.1
-
5
-
-
34548452615
-
A randomized trial of hyperfractionation versus standard fractionation in T2 squamous cell carcinoma of the vocal cord
-
Trotti A et al : A randomized trial of hyperfractionation versus standard fractionation in T2 squamous cell carcinoma of the vocal cord. Int J Radiat Oncol Biol Phys 66: S15, 2006
-
(2006)
Int J Radiat Oncol Biol Phys
, vol.66
-
-
Trotti, A.1
-
6
-
-
44449089921
-
Accelerated fractionation versus conventional fractionation radiation therapy for glottic cancer of T1-2N0M0 phase III study: Japan clinical oncology group study (JCOG 0701)
-
DOI 10.1093/jjco/hyn025
-
Nakamura K et al : Accelerated fractionation versus conventional fractionation radiation therapy for glottic cancer T1-2N0M0 phase III study : Japan Clinical Oncology Group Study (JCOG0701). Jpn J Clin Oncol 38: 387-389, 2008 (Pubitemid 351753572)
-
(2008)
Japanese Journal of Clinical Oncology
, vol.38
, Issue.5
, pp. 387-389
-
-
Nakamura, K.1
Kodaira, T.2
Shikama, N.3
Kagami, Y.4
Ishikura, S.5
Shibata, T.6
Hiraoka, M.7
-
7
-
-
33644538250
-
Radiation therapy for T2N0 laryngeal cancer: A retrospective analysis for the impact of concurrent chemotherapy on local control
-
DOI 10.1016/j.ijrobp.2005.10.003, PII S0360301605027380
-
Akimoto T et al : Radiation therapy for T2N0 laryngeal cancer: a retrospective analysis for the impact of concurrent chemotherapy on local control. Int J Radiat Oncol Biol Phys 64: 995-1001, 2006 (Pubitemid 43295292)
-
(2006)
International Journal of Radiation Oncology Biology Physics
, vol.64
, Issue.4
, pp. 995-1001
-
-
Akimoto, T.1
Nonaka, T.2
Kitamoto, Y.3
Ishikawa, H.4
Ninomiya, H.5
Chikamatsu, K.6
Furuya, N.7
Hayakawa, K.8
Mitsuhashi, N.9
Nakano, T.10
-
8
-
-
33749327580
-
Retrospective analysis: Concurrent chemoradiotherapy using protracted continuous infusion of low-dose cisplatin and 5-fluorouracil for T2N0 glottic cancer
-
DOI 10.1007/s11604-005-1517-1
-
Itoh Y et al : Retrospective analysis : concurrent chemotherapy using protracted continuous infusion of low-dose cisplatin and 5-fluorouracil for T2N0 glottic cancer. Radiat Med 24: 277-281, 2006 (Pubitemid 351194323)
-
(2006)
Radiation Medicine - Medical Imaging and Radiation Oncology
, vol.24
, Issue.4
, pp. 277-281
-
-
Itoh, Y.1
Fuwa, N.2
-
9
-
-
0036301622
-
"FAR" chemoradiotherapy improves laryngeal preservation rates in patients with T2N0 glottic carcinoma
-
Kumamoto Y et al : "FAR" chemoradiotherapy improves laryngeal preservation rates in patients with T2N0 glottic carcinoma. Head Neck 24 : 637-642, 2002
-
(2002)
Head Neck
, vol.24
, pp. 637-642
-
-
Kumamoto, Y.1
|